Isogenis, Inc.
Records under this name other than the patents Isogenis, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 3 of 3 · Back to Isogenis, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 5,242,687 | Method of reducing cellular immune response involving T-cells using CD8-bearing antigen presenting cells Term ended Term ended no later than Sep 7, 2013 · Low confidence | Term ended | Term ended no later than Sep 7, 2013 | Low confidence |
| US 5,601,828 | CD8 derivatives and methods of use for cellular modulation and enhancement of cellular engraftment Term ended Term ended no later than Feb 11, 2017 · Low confidence | Term ended | Term ended no later than Feb 11, 2017 | Low confidence |
| US 5,623,056 | CDS derivatives and methods of use for cellular modulation and enhancement of cellular engraftment Term ended Term ended no later than Apr 22, 2017 · Low confidence | Term ended | Term ended no later than Apr 22, 2017 | Low confidence |